Indications and uses
To relieve the symptoms of fainting.
Angelica sinensis, radix
- Manufacturer
- Washington Homeopathic Products
- Effective date
- 2016-07-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:08:23
Label at a glance#
ProductAngelica sinensis, radix
Active ingredientANGELICA SINENSIS ROOT
Label structure8 sections
Dosage and administration
Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS
ANGELICA SIN 30C
USES
To relieve the symptoms of fainting.
KEEP OUT OF REACH OF CHILDREN
Keep this and all medicines out of reach of children.
INDICATIONS
Indications:
ANGELICA SIN Irritability
STOP USE AND ASK DOCTOR
If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.
DIRECTIONS
Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.
INACTIVE INGREDIENTS
Sucrose/Lactose
PRINCIPAL DISPLAY PANEL
The OTC potency range of ANGELICA SIN is 3x–30x, 2c–30c, 200c, 1m, 10m, 50m, and CM.
Availability is subject to change.
All WHP single remedies are made to order; thus, the labels are printed on the same label stock as the orders are filled.
‘Bottle Size’ and ‘Potency’ vary on the label depending on customer choice.
Standard bottle sizes for pellet-form remedies are 2 dram, 4 dram, 1 ounce, 2 ounce, and 4 ounce.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68428-883-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f86-f424-e053-dadaa90a57ce | DRUG FACTS |
| 68428-883-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f86-f424-e053-dadaa90a57ce | DRUG FACTS |
| 68428-883-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f86-f424-e053-dadaa90a57ce | DRUG FACTS |
| 68428-883-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f86-f424-e053-dadaa90a57ce | DRUG FACTS |
| 68428-883-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1f86-f424-e053-dadaa90a57ce | DRUG FACTS |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68428-883-03 | Angelica sinensis, radix | 75 in 1 VIAL, GLASS | PELLET | 75 | 1 | |
| 68428-883-05 | Angelica sinensis, radix | 150 in 1 VIAL, GLASS | PELLET | 150 | 1 | |
| 68428-883-06 | Angelica sinensis, radix | 1200 in 1 BOTTLE, GLASS | PELLET | 1200 | 1 | |
| 68428-883-11 | Angelica sinensis, radix | 300 in 1 BOTTLE, GLASS | PELLET | 300 | 1 | |
| 68428-883-12 | Angelica sinensis, radix | 600 in 1 BOTTLE, GLASS | PELLET | 600 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Angelica sinensis, radix
- ANGELICA SINENSIS ROOT
- SUCROSE
- LACTOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68428-883 | 68428-883-03, 68428-883-05, 68428-883-11, 68428-883-12, 68428-883-06 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANGELICA SINENSIS ROOT | B66F4574UG | ACTIB |
| SUCROSE | C151H8M554 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a16d2e99-1916-41ab-9f0c-a7111b46ee58 | cac5ee3d-5a79-4af2-a121-e23ef643e32a | 2016-07-13 | Warnings | a16d2e99-1916-41ab-9f0c-a7111b46ee58 cac5ee3d-5a79-4af2-a121-e23ef643e32a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.